ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd half of 2023, following talks with the US Food... | June 19, 2023

Related Keywords

London ,City Of ,United Kingdom ,Tim Mccarthy ,Alliance News ,Avion Pharmaceuticals ,Us Food Drug Administration ,Alliance News Ltd ,Executive Officer Tim Mccarthy ,Sabrina Penty ,All Rights ,